Last update Oct. 24, 2023
It is a second generation antihistamine related to triprolidine. It has minimal sedative or antimuscarinic actions. It is used for symptomatic relief of allergic conditions such as rhinitis and urticaria. Oral administration three times a day.
At the time of the last update we found no published data on its excretion in breast milk.
Its low molecular weight and low binding to plasma proteins facilitate excretion in breast milk, but its high volume of distribution makes it difficult.
Pending further published data on this drug in relation to breastfeeding, safer known alternatives may be preferable, especially during the neonatal period and in case of prematurity.
Suggestions made at e-lactancia are done by APILAM team of health professionals, and are based on updated scientific publications. It is not intended to replace the relationship you have with your doctor but to compound it. The pharmaceutical industry contraindicates breastfeeding, mistakenly and without scientific reasons, in most of the drug data sheets.
Your contribution is essential for this service to continue to exist. We need the generosity of people like you who believe in the benefits of breastfeeding.
Thank you for helping to protect and promote breastfeeding.
e-lactancia is a resource recommended by Academy of Breastfeeding Medicine - 2006 of United States of America
Would you like to recommend the use of e-lactancia? Write to us at corporate mail of APILAM